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Background: Phagocytic clearance of apoptotic eosinophils plays an important role in the
successful resolution of asthmatic inflammation. To our knowledge, there is limited informa-
tion available on the effects of anti-asthma drugs on the ingestion of apoptotic eosinophils
by bronchial epithelial cells.
Aims: To evaluate the effects of dexamethasone, aminophylline and terbutaline on the inges-
tion of apoptotic eosinophils by A549 cells.
Methods: Eosinophils were purified by CD15 and CD16-dependent immunomagnetic selection
from peripheral blood of five normal donors. The capacity of phagocytosis of apoptotic eosin-
ophils by A549 cells were assessed under the microscope. IL-6 and IL-8 released from A549 cells
to the culture supernatants were measured by RIA.
Results: Dexamethasone enhanced the phagocytic capacity of A549 cells and inhibited the
production of IL-6 and IL-8 from A549 cells stimulated by LPS. Interestingly, aminophylline
and terbutaline could not only down-regulate the ingestion of apoptotic eosinophils by A549
cells in a time- and dose-dependent manner, but also decrease IL-6 and IL-8 secretion by
A549 cells induced by LPS.
Conclusions: The present study showed that all of the investigated anti-asthmatic drugs
including dexamethasone, aminophylline and terbutaline play an anti-inflammatory effect
by decreasing the release of IL-6 and IL-8 induced by LPS. On the other hand, they may have
a different effect on the phagocytosis of apoptotic eosinophils by A549 cells, i.e., dexameth-
asone promotes the uptake of apoptotic eosinophils while aminophylline and terbutaline
inhibit the ingestion of apoptotic eosinophils. These results revealed a novel aspect of dexa-
methasone, aminophylline and terbutaline in the treatment of asthma.
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Asthma is a complex inflammatory disease characterized by
reversible airway obstruction, bronchial hyper-reactivity,
inflammatory cells migration into the bronchial mucosa,
and airway remodeling.1,2 By participating in the cellecell
interactions to elicit chronic T helper 2 inflammations in
the lung, eosinophils are now considered as a principal
effecter cell in asthma.3e5 Removal of eosinophils via
apoptosis and concomitant phagocytosis offer a consider-
able potential to ameliorate asthmatic inflammation.6
Walsh et al. have demonstrated that both primary cultures
of human small airway epithelial cells and the alveolar
epithelial cell line A549 are capable of phagocytosing
apoptotic eosinophils.7 We also have demonstrated that
A549 cells can ingest apoptotic eosinophils by laser
confocal microscope slice scanning.8 These observations
demonstrate that airway epithelial cells are active partic-
ipants in the removal of apoptotic eosinophils and play an
important role in the resolution of eosinophilic inflamma-
tion in the asthmatic airway.
It has been shown that phagocytosis of apoptotic cells is
a highly regulated process. Maderna et al. demonstrated
that treatment of phagocytes with glucocorticoids, lipoxins
or even certain cytokines could markedly increase phago-
cytic clearance of apoptotic cells.9 Rossi et al. found that
elevation of cyclic adenosine monophosphate (cAMP) by
prostaglandins could down-regulate macrophage capacity
to ingest apoptotic cells.10 Interference with phagocytic
clearance of apoptotic cells may cause a delay of resolution
of inflammation and enhancers of the phagocytic process
may have therapeutic potential.11,12
Aminophylline, a nonselective phosphodiesterase (PDE)
inhibitor, has been used for over 60 years in the treatment
of asthma and chronic obstructive pulmonary disease
(COPD). Besides its bronchodilation function, aminophylline
has several anti-inflammatory activities including the inhi-
bition of cytokine synthesis and release, the inhibition of
inflammatory cell activation and microvascular leakage,
and immuno-modulatory effects.13 The b2-agonist terbu-
taline is commonly used to relieve bronchoconstriction.
Recent literatures have shown that it may be a potential
anti-inflammation agent.14,15 It remains unknown whether
aminophylline and terbutaline are involved in the clearance
of apoptotic eosinophils by bronchial epithelial cells.
The type II adenocarcinoma-derived cell line A549 has
been well characterized as being representative of alveolar
epithelial cells.16 We hypothesized that aminophylline and
terbutaline may also be involved in regulating the phago-
cytic clearance of apoptotic eosinophils and the production
of cytokines by A549 cells induced by LPS in vitro.
Materials and methods
Materials
Lipopolysaccharide (LPS), poly-L-lysine, o-dianisidine,
bovine serumalbumin (BSA), dexamethasone, aminophylline
and terbutaline were purchased from Sigma Ltd (Poole, UK).
Apoptotic annexin V-FITC kit was obtained from BD Biosci-
ences clontech (San Diego, CA, USA). Radioimmune assay kitsfor IL-6 and IL-8werepurchased fromthe immune technology
institute of General Hospital of People’s Liberation Army
(Beijing). Micromagnetic beads coated with anti-CD16 and
anti-CD15 were obtained from the Miltenyi Biotec (GmbH,
Bergisch Gladbach, Germany). Dulbecco’s modified Eagle
medium (DMEM) and fetal bovine serum (FBS) were obtained
from Invitrogen (Grand Island, USA).
Cell culture and eosinophil isolation
Blood (100 ml) was obtained from five normal donors with
informed consent. The concentration of eosinophil was not
greater than 0.5 106 eosinophils/ml. Eosinophils were
purified under sterile conditions by removal of red blood
cells using red blood cell lysis buffer, followed by CD15 and
CD16-dependent immunomagnetic selection, as previously
described.8 Using this method, eosinophils with a purity of
at least 99% were obtained. Purified eosinophils were
washed in DMEM and resuspended in the same medium with
10% fetal calf serum, 100 unit/ml penicillin and 100 mg/ml
streptomycin at 1 106 cells/ml. Cells were cultured for
48 h at 37 C in a humidified incubator with 5% CO2. After
aging, eosinophils were assessed for apoptosis by morpho-
logical assessment and annexin V-FITC apoptosis kit using
flow cytometry according to the manufacture’s instruc-
tions. All apoptotic cells used in the interaction/uptake
experiments were greater than 70% apoptotic.
Interaction assay
A549 cells were purchased from the American Tissue Culture
Collection and were maintained in DMEM supplemented with
10% fetal calf serum, 100 unit/ml penicillin and 100 mg/ml
streptomycin at 37 C under 5% CO2. Cultures were split at
95%e98% confluence by trypsin digestion and subcultured in
the same medium. Interaction assays were performed as
previously described.7 The A549 cells were trypsinized and
seeded into 24-well plates with 1000 cells per well and rested
for 1e2 days. After medium refreshment, cells were pre-
treated with dexamethasone, aminophylline or terbutaline
for the indicated duration of incubation at the required
concentrations. Cells involved dexamethasone treatments
were maintained in DMEM without phenol red supplemented
with 10% Charcoal-stripped fetal calf serum. Washed
apoptoticeosinophilswere resuspended inDMEMandadded to
eachwell (1 104)withA549 cells for 60 min at 37 Cunder 5%
CO2 as previously described.
8 After interaction, the non-
ingested eosinophils werewashed off using oscillatorwith PBS
solution supplemented with EDTA (0.02 mol/L) before fixa-
tion. The ingestedeosinophilswerevisualizedbyo-dianisidine
staining. At least 200 A549 cells which were counter-stained
with haematoxylin in duplicate wells in randomly selected
fields were counted by a blinded investigator, and the
proportion of ingested eosinophils was expressed as
a percentage.
Cytokine production
A549 cells were incubated in DMEM in 48-well plates with
dexamethasone (106 M), aminophylline (104 M), and ter-
butaline (1 mmol/L) for indicated duration of pretreatment.
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together with LPS (10 mg/mL) were added to each well for
60 min at 37 C. Then A549 cells were carefully washed and
250 ml DMEM was added to each well. The medium was
collected after 24 h, centrifuged, and stored at 80 C. IL-6
and IL-8 in the supernatants were measured by RIA kits
according to the manufacturer’s instruction.
Statistical analysis
All experiments were performed in triplicate for five inde-
pendent times. Data were expressed as the mean-
s standard error and were analyzed for significant
differences by unpaired Student’s t test and one-way
ANOVA with SPSS 10.0. Differences were considered
statistically significant if P value< 0.05.Results
Dexamethasone enhanced uptake of apoptotic
eosinophils by A549 cells
Ingested apoptotic eosinophils were visualized as dark
staining peroxidase-positive cells in blue A549 cells which
were counter-stained with haematoxylin as shown in
Figure 1A, B. These were confirmed that eosinophils had
been ingested by addition of trypsin to washed A549 cells
after their interaction with apoptotic eosinophils and laser
confocal microscope slice scanning with special fluorescentFigure 1 (A) and (B). Photomicrograph of un-stimulated and stim
Apoptotic eosinophils were seen as condensed peroxidase-positive
counter-stained with haematoxylin(400). (C) The effects of dexa
taline(1 mmol/L) and aminophylline (104 mol/L) pretreatment on
expressed as percentage of phagocytosis SE. LPS and DXM up-
regulated the ingestion of apoptotic eosinophils by A549 cells
AE: apoptotic eosinophil; AM: aminophylline; TBT: terbutaline.agents as we previously reported. Regulatory effects of
dexamethasone on the ingestion of apoptotic eosinophils by
A549 cells in various durations were shown in Figure 2A.
Dexamethasone enhanced the capacity of engulfment to
the highest at the 4 time point and weakened after 24 h of
pre-incubation that was still significantly higher compared
with control (0 h). Interestingly, glucocorticoid antagonist
RU38486 had no effect on the ingestion of apoptotic
eosinophils by A549 cells; it blocked the enhancement of
phagocytosis, as shown in Figure 2B.
Aminophylline and terbutaline inhibited
engulfment of apoptotic eosinophils by A549 cells
in a time- and dose-dependent manner
We assessed the effects of aminophylline or terbutalline on
the uptake of apoptotic eosinophils by A549 cells at
different time-duration and dose-range. After 24 h
pretreatment with aminophylline at the concentration of
104 mol/L, the capacity of A549 cells to ingest apoptotic
eosinophils was significantly down-regulated. In addition,
the longer duration of pretreatment and higher concen-
tration of aminophylline, the clearance capacity of A549
cells were declined (Figure 3A). Designed concentration as
low as 105 mol/L, aminophylline had no effect on the
capacity of A549 cells to ingest apoptotic eosinophils no
matter how long the pretreatment duration was
(Figure 3A). As early as 1 h after pretreatment, terbutaline
at the concentration of 1 mmol/L could inhibit the capacity
of A549 cells to ingest apoptotic eosinophils. With longerulated A549 cells that have ingested the apoptotic eosinophils.
dark staining bodies (/) within the blue A549 cells which were
methasone(106 mol/L), lipopolysaccharide(10 mg/mL), terbu-
the ingestion of apoptotic eosinophils by A549 cells. Data are
regulated the ingestion ()P< 0.05) while AM and TBT down-
())P< 0.05). DXM: dexamethasone; LPS: lipopolysaccharide;
Figure 2 (A) Time course of augmentation of A549 cells phagocytosis of apoptotic eosinophils pre-incubation with dexameth-
asone (106 mol/L). Each bar represents the mean SEM of 5 separate experiments in which the number of ingested apoptotic
eosinophils inside 200 resting or cytokine-stimulated A549 cells were counted. )P< 0.05 vs control values. (B) Glucocorticoid
antagonist RU38486 blocked the enhancement of phagocytosis of apoptotic eosinophils by A549 cells. Each bar represents the
mean SEM. )P< 0.05 vs control values.
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the inhibitory effect was apparent. 0.1 mmol/L terbutaline
had no effect on the capacity of A549 cells to ingest
apoptotic eosinophils (Figure 3B). Therefore, aminophylline
and terbutaline inhibited engulfment of apoptotic eosino-
phils by A549 cells in a time- and dose-dependent manner.
Dexamethasone, aminophylline and terbutaline
inhibited IL-6 and IL-8 secretion from A549 cells
induced by LPS
We next assayed the effect of dexamethasone, aminophyl-
line and terbutaline pretreatment on the IL-6 and IL-8
production from A549 cells induced by LPS. The levels of IL-6
and IL-8 were decreased by dexamethasone, aminophylline
and terbutaline pretreatment. Phagocytosis of apoptoticFigure 3 The effect on the uptake of apoptotic eosinophils by A5
aminophylline (A) and terbutaline (B). The capacity of A549 cells to
with longer duration and increasing concentrations. Each bar repr
control values (0 mol/L), 6 P< 0.05 different duration of pre-incueosinophils failed to induce obvious release of IL-6 and IL-8
from un-stimulated A549 cells (Figure 4A, 4B). After inges-
tion of apoptotic eosinophils, there were also no obvious
release of IL-6 and IL-8 from dexamethasone, inophylline
and turbutaline pre-treated A549 cells induced by LPS
(Figure 5A and B).
Discussion
Amongst the anti-asthma drugs, glucocorticoids are by far
the most effective ones in controlling asthma, although the
exact mechanisms underlying therapeutic efficacy remain
unclear. There are substantial evidences that glucocorti-
coids (in particular dexamethasone) might exert some of
their anti-inflammatory effects in patients with asthma by
influencing apoptosis and apoptotic-cell clearance by49 cells after stimulation with time-duration and dose-range of
ingest apoptotic eosinophils was down-regulated and declined
esents the mean SEM. )P< 0.05 different concentrations vs
bation vs initial time.
Figure 4 The effect of dexamethasone, aminophylline and terbutaline on IL-6(A) and IL-8(B) production from A549 cells induced
by LPS. Each bar represents the mean SEM. )P< 0.05 vs control values (nZ 5).
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et al. found that dexamethasone enhanced the number of
A549 cells ingesting apoptotic eosinophils in a dose-
dependent pattern with the optimal concentration at
106 M.19 In the present study, we found that 106 M
dexamethasone enhanced the phagocytic clearance of
apoptotic eosinophils by A549 cells in time course manner
and this effect was blocked by addition of the glucocorti-
coids receptor antagonist RU38486 (10 mM), indicating that
glucocorticoid receptor was involved in this process. These
observations may help to explain the previous studies.19,20
To our knowledge, we reported for the first time the
effect of aminophylline and terbutaline on the clearance of
apoptotic eosinophils by A549 cells. Unlike dexamethasone,
aminophylline and terbutaline inhibited A549 cells from
ingestion of apoptotic eosinophils in a time- and dose-
dependent manner.
The concentration of aminophylline and dexamethasone
assigned in this research covered the therapeutic dose in
the clinic.21e23 Our observation indicated that at thera-
peutic concentrations, dexamethasone, aminophylline and
terbutaline have exerted significant effects on the phago-
cytic clearance of apoptotic eosinophils by A549 cells.
These results revealed a novel aspect of dexamethasone,
aminophylline and terbutaline in the treatment of asthma.Figure 5 The effect of dexamethasone, aminophylline and terbut
by LPS after ingestion of apoptotic eosinophils. Each bar representAirway epithelial cells are potent sources of pro-
inflammatory substances such as GM-CSF, IL-6, IL-11 and IL-
8.24,25 IL-6 and IL-8 can enhance the adhesion of leukocytes
to LPS-treated airway epithelial cells and stimulate cell
signaling cascades, resulting in specific immune and
inflammatory responses.26,27 A large number of studies
have demonstrated that phagocytosis of apoptotic cells by
macrophages not only failed to release phlogistic agents,
but also could actually suppress the inflammatory response.
In the present study, we found that phagocytosis of
apoptotic eosinophils decreased the production of IL-6 and
IL-8 from LPS stimulated A549 cells and failed to increase
the IL-6 and IL-8 release from un-stimulated A549 cells. Liu
et al. demonstrated that glucocorticoids promoted non-
phlogistic phagocytosis of apoptotic leukocytes and Stern
found that lipoxins could rapidly stimulate nonphlogistic
phagocytosis of apoptotic neutrophils by monocyte-derived
macrophages.28,29 Ren et al. reported that apoptotic cells
may protect mice against LPS induced shock.30 Our findings
were consistent with these results. Therefore, enhance-
ment of nonphlogistic clearance of apoptotic cells may has
potential implications for therapies aimed at promoting the
resolution of inflammatory diseases.
Accumulating evidences have shown that aminophylline
and terbutaline exert anti-inflammatory effects on cellsaline on IL-6(A) and IL-8(B) production from A549 cells induced
s the mean SEM. )P< 0.05 vs control values (nZ 5).
1698 J. Wang et al.exposed to LPS,31,32 though the underlying mechanisms are
still currently investigated. Yoshimura et al. demonstrated
that aminophylline is effective at modulation of Th1- and
Th2-like cytokine production and b2-agonists increased the
effect.33 Strandberg et al. found that b2-agonists induced
enhancement of IL-6 and IL-8 release from primary bronchial
epithelial cells and A549 cells stimulated with organic dust
from pig barns.34 In the present study, we found that
aminophylline and terbutaline can inhibited the production
of IL-6 and IL-8 from A549 cells induced by LPS. These results
indicate that they may play anti-inflammatory effects by
decreasing the release of IL-6 and IL-8 from the bronchial
epithelial cells in asthmatic inflammatory condition.
In conclusion, the present study showed that all of the
investigated anti-asthmatic drugs including dexametha-
sone, aminophylline and terbutaline play an anti-inflam-
matory effect by decreasing the release of IL-6 and IL-8
induced by LPS. On the other hand, they may have
a different effect on the phagocytosis of apoptotic eosin-
ophils by A549 cells, i.e., dexamethasone promotes the
uptake of apoptotic eosinophils while aminophylline and
terbutaline inhibit the ingestion of apoptotic eosinophils.
These results revealed a novel aspect of dexamethasone,
aminophylline and terbutaline in the treatment of asthma.
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